Chicago, IL

TCC Signs Another Life Sciences Tenant at Fulton Labs in Chicago

Charles River Laboratories Leased 8,800 Square Feet at 1375 West Fulton

May 15, 2023

Aerial of Fulton Labs in Chicago, Illinois with city skyline in background

Media Contact

Elise Maguire Ferrara

Senior Manager, U.S. Communications & Media

Photo of elise-maguire

Trammell Crow Company (TCC), a global commercial real estate developer, signed a lease with Charles River Laboratories’ (CRL), at its Fulton Labs campus in Chicago. The company will occupy 8,776 square feet of space on the seventh floor of 1375 West Fulton, which together with nearby 400 North Aberdeen, makes up TCC’s 725,000-square-foot Fulton Labs life sciences campus.

“Watching Fulton Labs come to life over the last few years has been an incredible journey for TCC and our project partners. The state-of-the-art campus is attracting users in the life sciences space that are seeking high-quality lab and office space that affords them an opportunity to grow in Chicago. We are energized to see the continued interest in the Fulton Labs properties, as well as the heighted interest in Chicago as a top-tier life sciences market,” said Morgan Baer-Blaska, Vice President with TCC. “We look forward to welcoming CRL into their new space at Fulton Labs later this year.”

CRL’s CRADL business already occupies 10,000 square feet on the ground floor at 1375 West Fulton. The campus was designed to meet the needs of the growing companies like CRL, which will use their expansion space to accelerate and augment their own clients’ discovery efforts.

TCC was represented in the transaction by Dan Lyne and Kelsey Scheive of CBRE. The tenant was represented by Paul Giannopulos, Matt Schiffler, Brendan Callahan, and Peter Skerrett of JLL.

Other tenants at Fulton Labs include Chan Zuckerberg Biohub Chicago, Dimension Inx, Celadyne Technologies, Portal Innovations, Xeris Pharmaceuticals, Vanqua Bio and Talis Biomedical.

Trammell Crow Company

Trammell Crow Company (TCC) is a global commercial real estate developer and wholly-owned subsidiary of CBRE Group, Inc. (NYSE:CBRE), a Fortune 500 and S&P 500 company headquartered in Dallas. Founded in 1948, TCC has developed or acquired nearly 2,900 buildings valued at $75 billion and over 655 million square feet. As of December 31, 2023, TCC had $15.8 billion of projects in process and $13.3 billion in its pipeline. It employs 650 professionals in 26 major cities throughout the United States and Europe. The company serves users of and investors in office, industrial/logistics, healthcare, life sciences and mixed-use projects, as well as multi-family residential through its operating subsidiary High Street Residential. For more information visit